Results 251 to 260 of about 61,183 (295)
Muscle loss in cancer cachexia: what is the basis for nutritional support? [PDF]
Front PharmacolFaiad J +6 more
europepmc +1 more source
Stool Microbiome Features and Weight Change Response to Treatment for cancer cachexia. [PDF]
J Cachexia Sarcopenia MuscleNasrah R +5 more
europepmc +1 more source
Six-Minute Walk Test Is Superior to Grip Strength as a Marker of Functional Recovery During Cancer Cachexia Rehabilitation. [PDF]
J Cachexia Sarcopenia MuscleBarber A +7 more
europepmc +1 more source
Profibrotic immune cells and fibro-adipogenic progenitors contribute to skeletal muscle extracellular matrix remodeling and fibrosis in cancer cachexia. [PDF]
Am J Physiol Cell PhysiolCardaci TD +9 more
europepmc +1 more source
Challenges in Targeting the "Crosstalks" in Cancer Cachexia. [PDF]
South Asian J CancerVallathol DH, Warrier AR.
europepmc +1 more source
Separating food intake-dependent and -independent effects in cancer cachexia
Liang Y, Kwon Y, Hui S.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Clinical Journal of Oncology Nursing
Cancer cachexia is characterized by metabolic dysregulation, inflammation, and reduced food intake, and it results in loss of skeletal muscle. Although cachexia is pervasive in patients with advanced cancer, comprehensive cac.
Michael S Yule +3 more
+7 more sources
Cancer cachexia is characterized by metabolic dysregulation, inflammation, and reduced food intake, and it results in loss of skeletal muscle. Although cachexia is pervasive in patients with advanced cancer, comprehensive cac.
Michael S Yule +3 more
+7 more sources
International Journal of Oncology, 1997
Cancer cachexia is a complex syndrome accounting for nearly a third of cancer deaths, characterized by weight loss, anorexia, weakness, anaemia and asthenia. The complications associated with the appearance of the cachectic syndrome affect both the physiological and biochemical balance of the patient, and have effects on the efficiency of the ...
J, Argiles, F, Lopezsoriano
openaire +2 more sources
Cancer cachexia is a complex syndrome accounting for nearly a third of cancer deaths, characterized by weight loss, anorexia, weakness, anaemia and asthenia. The complications associated with the appearance of the cachectic syndrome affect both the physiological and biochemical balance of the patient, and have effects on the efficiency of the ...
J, Argiles, F, Lopezsoriano
openaire +2 more sources
International journal of pancreatology, 1990
Cancer cachexia has been listed as a major cause of death in cancer patients. In order to investigate the metabolic effects of the tumor on the host, we have evaluated an experimental model of cancer cachexia in the mouse (MAC16 colon adenocarcinoma), in which weight loss can reach 30-40% of initial weight with a tumor burden of only 2.5%, without a ...
M J, Tisdale, S A, Beck
openaire +2 more sources
Cancer cachexia has been listed as a major cause of death in cancer patients. In order to investigate the metabolic effects of the tumor on the host, we have evaluated an experimental model of cancer cachexia in the mouse (MAC16 colon adenocarcinoma), in which weight loss can reach 30-40% of initial weight with a tumor burden of only 2.5%, without a ...
M J, Tisdale, S A, Beck
openaire +2 more sources
International Journal of Cardiology, 2002
Cancer cachexia is a complex, multifactorial syndrome that results from a reduction in food intake, a variety of metabolic abnormalities (including hypermetabolism) or more often a combination of the two. Multiple mediator pathways including pro-inflammatory cytokines, neuroendocrine hormones and tumour-specific factors are involved. Therapy requires a
Kenneth C H, Fearon, Alastair G W, Moses
openaire +2 more sources
Cancer cachexia is a complex, multifactorial syndrome that results from a reduction in food intake, a variety of metabolic abnormalities (including hypermetabolism) or more often a combination of the two. Multiple mediator pathways including pro-inflammatory cytokines, neuroendocrine hormones and tumour-specific factors are involved. Therapy requires a
Kenneth C H, Fearon, Alastair G W, Moses
openaire +2 more sources